CROSS HERB has filed 4 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 90000 shares of Jasper Therapeutics, Inc. ($JSPR) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Jasper Therapeutics, Inc. | $JSPR | CROSS HERB | Chief Financial Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 16,635,784 | 9999.99% | 0.54% |
| June 4, 2025 | Jasper Therapeutics, Inc. | $JSPR | CROSS HERB | Chief Financial Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 15,022,122 | 9999.99% | 0.60% |
| Feb. 13, 2025 | Jasper Therapeutics, Inc. | $JSPR | CROSS HERB | Chief Financial Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 14,584,870 | 9999.99% | 0.34% |
| Feb. 15, 2024 | Jasper Therapeutics, Inc. | $JSPR | CROSS HERB | Chief Financial Officer | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 10,439,034 | 9999.99% | 0.38% |